Cargando…
Nanoengineered mesenchymal stem cell therapy for pulmonary fibrosis in young and aged mice
Pulmonary fibrosis (PF) is an age-related interstitial lung disease that results in notable morbidity and mortality. The Food and Drug Administration–approved drugs can decelerate the progression of PF; however, curing aged patients with severe fibrosis is ineffective because of insufficient accumul...
Autores principales: | Han, Meng-Meng, He, Xing-Yue, Tang, Ling, Qi, Liang, Yang, Ming-Yuan, Wang, Yi, Xing, Lei, Jeong, Jee-Heon, Jiang, Hu-Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355834/ https://www.ncbi.nlm.nih.gov/pubmed/37467328 http://dx.doi.org/10.1126/sciadv.adg5358 |
Ejemplares similares
-
Nanoengineered on-demand drug delivery system improves efficacy of pharmacotherapy for epilepsy
por: Wu, Di, et al.
Publicado: (2022) -
Engineering of hybrid spheroids of mesenchymal stem cells and drug depots for immunomodulating effect in islet xenotransplantation
por: Nguyen, Tiep Tien, et al.
Publicado: (2022) -
NPRC deletion attenuates cardiac fibrosis in diabetic mice by activating PKA/PKG and inhibiting TGF-β1/Smad pathways
por: Meng, Linlin, et al.
Publicado: (2023) -
Intracellular delivery of nitric oxide enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarction
por: Hao, Tian, et al.
Publicado: (2023) -
Small extracellular vesicles from young adipose-derived stem cells prevent frailty, improve health span, and decrease epigenetic age in old mice
por: Sanz-Ros, Jorge, et al.
Publicado: (2022)